Identification of gene expression signatures and related microRNAs for chronic glomerulonephritis based on microarray and bioinformatic analysis
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1032133 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:To further reveal the key genes and related microRNAs involved in the CGN and to determine the potential molecular mechanisms of CGN pathogenesis. We have employed microarray expression profiling as a discovery platform to identify genes and related microRNAs. To identify the key ceRNA in CGN, we generated a ceRNA network using data from the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO). 2334 differentially regulated genes and a total of 673 related miRNAs were identified. We found that the ceRNA network was composed of 31 lncRNAs, 344 mRNAs, and 57 miRNAs. Expression of five genes (FOS, SYK, CYP1A1, HSD3B6, UGT2B15), five microRNAs (miR-34a-5p, miR-214-3p, miR-155-5p, miR-182, miR-592), three lncRNAs (LOC102547703, NONRATT006779, FQ220365) were quantified in the same RNA samples by real-time PCR, which could be potential diagnostic biomarkers and therapeutic targets for CGN.
2023-10-30 | GSE246257 | GEO
Project description:Bioinformatic Analysis of Aniridia Related Keratopathy
| PRJNA761786 | ENA
Project description:Single-cell TCR sequencing of T cells from ANCA-associated glomerulonephritis patients and experimental crescentic glomerulonephritis mouse model.
2023-03-31 | GSE223107 | GEO
Project description:Analysis of glomeruli isolated from kidneys of 4 month male BXSB/MpJ-Yaa. The BXSB/MpJ-Yaa mouse strain is a lupus-prone model. Results provide insight into the pathogenic mechanisms linked to glomerulonephritis in BXSB/MpJ-Yaa mice. The glomeruli were isolated from 6 BXSB/MpJ-Yaa (glomerulonephritis model) and BXSB/MpJ-Yaa+ (control). 6 glomerular populations of each strain were devided into 3 groups (1 group / 2 populations). 3 glomerulonephritis models versus 3 controls analysis was performed. BXSB/MpJ-Yaa is a recombinant inbred strain developed originally from a C57BL/6 female mouse and a SB/Le male mouse. Yaa (Y-linked autoimmune accelerator locus) localizing on the Y chromosome of BXSB/MpJ-Yaa male mice is the result of a duplication of an about 4 Mbp telomeric segment near the pseudoautosomal region of the X chromosome onto the Y chromosome. BXSB/MpJ-Yaa+ (control) male mice carry the wild-type Y chromosome in place of the mutant Yaa-containing Y chromosome of BXSB/MpJ-Yaa male mice.
2014-01-01 | E-GEOD-51230 | biostudies-arrayexpress
Project description:Evolution of glomerulonephritis (GN) to tubulointerstitial disease is a universal antecedent to the development of chronic kidney disease (CKD). There is also evidence that angiotensin converting enzyme (ACE) inhibition may attenuate the development of CKD in some forms of glomerulonephritis. We tested the role of ACE inhibition in a model of GN in which complement-dependent tubulointerstitial disease develops. GN was induced in C57BL/6 mice with intraperitoneal injections of horse spleen apoferritin (HSA) using lipopolysaccharide (LPS) as an adjuvant. Four groups of six animals were studied: saline-injected control mice treated with captopril or water, and GN mice treated with captopril or water. GN developed in all HSA-treated animals. In those receiving captopril, however, proteinuria (albumin/creatinine ratio) was significantly reduced by captopril treatment. Array screening was used to examined the expression of collagen-related genes and determine if these effects could be mediated by regulation of collagen genes. Six genes were identified for further analysis by quantitative RT-PCR. This model demonstrates that tubulointerstitial disease can be attenuated by ACE inhibition, with clinical, histologic, and gene expression measures. All protocols were approved by the Institutional Animal Care and Use Committee at SUNY Upstate Medical University. We employed four groups of six mice each: saline-injected control mice with and without captopril, and GN with and without captopril. C57BL/6 mice were purchased from The Jackson Laboratories (Bar Harbor, ME). Glomerulonephritis (GN) was induced by intraperitoneal (i.p.) injection of 10 mg of apoferritin from horse spleen (HSA, Sigma, St. Louis, MO) five days per week, with i.p. injection of 100 micrograms lipopolysaccharide (LPS, from Salmonella minnesota; EMD Biosciences, La Jolla, CA), as adjuvant, three times per week. Control animals received equal volumes of 0.15 M NaCl by i.p. injection. Injections were begun when the mice were approximately eight weeks of age and were continued for six weeks. Captopril, at 100 mg/kg/day was given in the drinking water. After 9 weeks, the animals were euthanized and kidneys were removed for RNA purification and analysis.
2013-07-30 | E-GEOD-49323 | biostudies-arrayexpress
Project description:Evolution of glomerulonephritis (GN) to tubulointerstitial disease is a universal antecedent to the development of chronic kidney disease (CKD). There is also evidence that angiotensin converting enzyme (ACE) inhibition may attenuate the development of CKD in some forms of glomerulonephritis. We tested the role of ACE inhibition in a model of GN in which complement-dependent tubulointerstitial disease develops. GN was induced in C57BL/6 mice with intraperitoneal injections of horse spleen apoferritin (HSA) using lipopolysaccharide (LPS) as an adjuvant. Four groups of six animals were studied: saline-injected control mice treated with captopril or water, and GN mice treated with captopril or water. GN developed in all HSA-treated animals. In those receiving captopril, however, proteinuria (albumin/creatinine ratio) was significantly reduced by captopril treatment. Array screening was used to examined the expression of collagen-related genes and determine if these effects could be mediated by regulation of collagen genes. Six genes were identified for further analysis by quantitative RT-PCR. This model demonstrates that tubulointerstitial disease can be attenuated by ACE inhibition, with clinical, histologic, and gene expression measures.
2013-07-30 | GSE49323 | GEO
Project description:In isolated glomeruli by beads-perfusion methods, microRNA (miRNA) expression was analyzed in healthy C57BL/6 and B6.MRLc1 glomerulonephritis mice. The expression of 1,135 miRNAs was examined, and up-regulated or down-regulated miRNA was determined. These results provide a basical information of molecular pathology in glomerulonephritis. The glomeruli were collected from female C57BL/6 (n=3, 9-month-old, healthy control) and female B6.MRLc1 (n=3, 14-month-old, early stage of glomerulonephritis; n=3, 9-month-old, late stage of glomerulonephritis). The total RNA sample was purified, and total 1,135 microRNA expression was compared among healthy, early stage, and late stage.
2014-10-01 | E-GEOD-51209 | biostudies-arrayexpress
Project description:This study examined the role of local complement synthesis in a mouse model of glomerulonephritis, which evolves into progressive tubulointerstitial disease. The model was used to quantitate clinical, histologic, and transcriptomic outcomes, and assess the role of angiotensin conversting enzyme (ACE) inhibition in modifying these measures. We also comprehensively explored the biological pathways and networks exhibiting alterations in gene expression to provide further insight into the role of ACE inhibition in the model.
2018-08-01 | GSE117917 | GEO
Project description:Analysis of glomeruli isolated from kidneys of 4 month male BXSB/MpJ-Yaa. The BXSB/MpJ-Yaa mouse strain is a lupus-prone model. Results provide insight into the pathogenic mechanisms linked to glomerulonephritis in BXSB/MpJ-Yaa mice.
2014-01-01 | GSE51230 | GEO
Project description:ANCA Glomerulonephritis: From Molecules to Man
| PRJNA671246 | ENA